Early Phase Cancer Immunotherapy
Produktform: E-Buch Text Elektronisches Buch in proprietärem
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.weiterlesen
Dieser Artikel gehört zu den folgenden Serien
149,79 € inkl. MwSt.
Recommended Retail Price
kostenloser Versand
lieferbar - Lieferzeit 10-15 Werktage
zurück